NL-OMON38747
Completed
Not Applicable
VALIDATION OF THE INTERNATIONAL PAEDIATRIC MITOCHONDRIAL DISEASE SCORE - INTERNATIONAL PAEDIATRIC MITOCHONDRIAL DISEASE SCORE
niversitair Medisch Centrum Sint Radboud0 sites8 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitair Medisch Centrum Sint Radboud
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. 0 to 18 years of age
- •2\. Mitochondrial disorder established by a confirmed mutation in mtDNA or nuclear DNA
Exclusion Criteria
- •\- it is estimated that the study will be too burdensome to the patient
- •\- insufficient knowledge of the Dutch language
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Optimization of the International Paediatric Mitochondrial Disease ScaleNL-OMON43155niversitair Medisch Centrum195
Not yet recruiting
Phase 2
An implementation of pediatric hospital-acquired malnutrition (PHaM) risk score to reduce hospital-acquired malnutrition among Pediatric Patients: An interrupted time series analysisHospital-acquired malnutrition, Hospital-aquired infectionHospital-acquired malnutritionTCTR20220705004Khon Kaen university100
Completed
Not Applicable
SELECTING OUTCOME MEASURES IN PAEDIATRIC MITOCHONDRIAL ENCEPHALOPATHY: A PILOT STUDYNL-OMON45750niversitair Medisch Centrum20
Active, not recruiting
Not Applicable
Validity and reliability of the German 'Pediatric Balance Scale' in children with neuromotor disordersG80-G83S06I60-I69Cerebral palsy and other paralytic syndromesIntracranial injuryCerebrovascular diseasesDRKS00015707Rehabilitationszentrum für Kinder und Jugendliche Universitäts-Kinderspital Zürich30
Completed
Phase 4
An Observational, multinational Heart Failure disease registry study to identify routine patterns of diagnosis & medical care for patients of acute heart failure as well as treatment type,long term heart failure related clinical events and re-admission rates during the followup period of 3 years.CTRI/2015/01/005389ovartis AG1,539